Perforomist is a solution formulation of the long-acting beta 2-agonist formoterol fumarate, which is administered by inhalation via nebulization. It acts as a bronchodilator by stimulating beta 2 ...

Following positive Phase IIa results for oral Rentosertib in GENESIS-IPF with good tolerability, a favorable PK profile, and ...

Please provide your email address to receive an email when new articles are posted on . Tobramycin inhalation solution was effective in lowering bacterial density and positively influenced quality of ...

Xopenex (levalbuterol) is a brand-name inhaled medication prescribed to treat and help prevent difficulty breathing associated with bronchospasm. Xopenex comes in two forms: a solution for use with a ...

Bitop AG Announces Start of Clinical Trial with Ectoin Inhalation Solution in Patients with Inflammation and Obstruction of the Airways | Witten, Germany, November 04, 2010 / b3c newswire / - bitop AG ...

King Pharmaceuticals has decided to discontinue manufacturing Intal nebulizer solution (cromolyn sodium inhalation solution). The decision is based upon many factors, including the company’s ...

Ritedose Pharmaceuticals has received the Food and Drug Administration’s approval for manufacturing and distributing generic albuterol sulfate inhalation solution, 0.5% (2.5 mg/0.5 ml). "Driven by the ...

Brovana (arformoterol tartrate) is a prescription drug used to treat chronic obstructive pulmonary disease (COPD) in adults. Brovana comes as a liquid solution that’s used in a jet nebulizer device.

- LONHALA MAGNAIR is the first nebulized long-acting muscarinic antagonist (LAMA) approved for the treatment of COPD in the U.S. - MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc.

As demonstrated in preclinical studies, the inhalation solution of ISM001-055 is well tolerated with good anti-fibrotic and anti-inflammatory efficacy, favorable safety and pharmacokinetic (PK) ...

Yupelri (revefenacin) is a prescription drug used to help manage chronic obstructive pulmonary disease (COPD). Yupelri comes as a liquid solution you inhale using a specific nebulizer. Yupelri is used ...

Teva announced the launch of Tobramycin Inhalation Solution, the generic version of Novartis‘ Tobi. Tobi is approved for the management of cystic fibrosis in patients with Pseudomonas aeruginosa.